EUVIMEDEUVIMED entdecken
Crossref

Alogliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Joshua J. Neumiller and Paul Milani

Clinical Medicine Reviews in Vascular Health · 2011

DOI: 10.4137/cmrvh.s3318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Reviews in Vascular Health, 2011. Verfasst von Joshua J. Neumiller and Paul Milani.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Milani, J. J. N. A. P. (2011). Alogliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus. Clinical Medicine Reviews in Vascular Health. https://doi.org/10.4137/cmrvh.s3318

Vancouver

Milani JJNAP. Alogliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus. Clinical Medicine Reviews in Vascular Health. 2011. doi:10.4137/cmrvh.s3318

BibTeX
@article{Milani2011,
  author = {Milani, Joshua J. Neumiller and Paul},
  title = {Alogliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus},
  journal = {Clinical Medicine Reviews in Vascular Health},
  year = {2011},
  doi = {10.4137/cmrvh.s3318}
}
Kostenlos starten →